S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

实时更新: HilleVax, Inc. [HLVX]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
BUY
50.00%
return 3.19%
SELL
0.00%
return 3.82%
最后更新时间4 May 2024 @ 04:00

-2.92% $ 13.61

出售 114974 min ago

@ $14.70

发出时间: 14 Feb 2024 @ 22:30


回报率: -7.41%


上一信号: Feb 13 - 22:30


上一信号: 购买


回报率: -1.47 %

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection...

Stats
今日成交量 59 743.00
平均成交量 158 574
市值 676.70M
EPS $-0.810 ( 2024-03-22 )
下一个收益日期 ( $-0.840 ) 2024-05-10
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.48
ATR14 $0.0320 (0.24%)
Insider Trading
Date Person Action Amount type
2024-05-01 Kohli Aditya Sell 175 Common Stock
2024-05-02 Kohli Aditya Sell 6 000 Common Stock
2024-05-03 Kohli Aditya Sell 723 Common Stock
2024-04-04 Frazier Life Sciences X, L.p. Buy 8 850 Common Stock
2024-04-03 Kohli Aditya Sell 6 000 Common Stock
INSIDER POWER
-5.76
Last 79 transactions
Buy: 14 572 379 | Sell: 83 230 006

音量 相关性

長: 0.07 (neutral)
短: -0.57 (weak negative)
Signal:(36.51) Neutral

HilleVax, Inc. 相关性

10 最正相关
SLDP0.881
FONR0.86
RDHL0.859
HOOK0.857
GRAY0.856
BIMI0.856
TC0.843
RBKB0.836
EQIX0.835
MARPS0.834
10 最负相关
OPNT-0.863
EWEB-0.862
EDUT-0.857
BNIXU-0.855
NTUS-0.854
DVCR-0.854
MGI-0.843
CIH-0.842
NUTX-0.839
AVEO-0.831

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

HilleVax, Inc. 相关性 - 货币/商品

The country flag -0.67
( moderate negative )
The country flag -0.38
( neutral )
The country flag 0.00
( neutral )
The country flag -0.70
( moderate negative )
The country flag -0.60
( weak negative )
The country flag 0.76
( moderate )

HilleVax, Inc. 财务报表

Annual 2023
营收: $0
毛利润: $-2.16M (0.00 %)
EPS: $-3.04
FY 2023
营收: $0
毛利润: $-2.16M (0.00 %)
EPS: $-3.04
FY 2022
营收: $0
毛利润: $-2.25M (0.00 %)
EPS: $-6.83
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-6.29

Financial Reports:

No articles found.

HilleVax, Inc.

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。